117 related articles for article (PubMed ID: 27609113)
1. Cefazolin pharmacokinetics in cats under surgical conditions.
Albarellos GA; Montoya L; Passini SM; Lupi MP; Lorenzini PM; Landoni MF
J Feline Med Surg; 2017 Oct; 19(10):992-997. PubMed ID: 27609113
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of intravenous ketorolac in cats undergoing gonadectomy.
Villa R; Ravasio G; Ferraresi C; Zonca A; Carli S; Borghi L; Cagnardi P
N Z Vet J; 2015 May; 63(3):162-6. PubMed ID: 25523103
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
Manley HJ; Bailie GR; Asher RD; Eisele G; Frye RF
Perit Dial Int; 1999; 19(1):65-70. PubMed ID: 10201343
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tissue concentrations of cefazolin in pediatric patients undergoing gastrointestinal surgery.
Nahata MC; Durrell DE; Ginn-Pease ME; King DR
Eur J Drug Metab Pharmacokinet; 1991; 16(1):49-52. PubMed ID: 1936061
[TBL] [Abstract][Full Text] [Related]
5. Does intraoperative blood loss affect antibiotic serum and tissue concentrations?
Swoboda SM; Merz C; Kostuik J; Trentler B; Lipsett PA
Arch Surg; 1996 Nov; 131(11):1165-71; discussion 1171-2. PubMed ID: 8911256
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery.
Lanckohr C; Horn D; Voeller S; Hempel G; Fobker M; Welp H; Koeck R; Ellger B
J Thorac Cardiovasc Surg; 2016 Aug; 152(2):603-10. PubMed ID: 27209020
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis.
Manley HJ; Bailie GR; Frye R; Hess LD; McGoldrick MD
J Am Soc Nephrol; 2000 Jul; 11(7):1310-1316. PubMed ID: 10864588
[TBL] [Abstract][Full Text] [Related]
8. Comparative total and unbound pharmacokinetics of cefazolin administered by bolus versus continuous infusion in patients undergoing major surgery: a randomized controlled trial.
Naik BI; Roger C; Ikeda K; Todorovic MS; Wallis SC; Lipman J; Roberts JA
Br J Anaesth; 2017 Jun; 118(6):876-882. PubMed ID: 28505360
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass in adult patients undergoing cardiac surgery.
Asada M; Nagata M; Mizuno T; Uchida T; Takahashi H; Makita K; Arai H; Kijima S; Echizen H; Yasuhara M
Eur J Clin Pharmacol; 2021 May; 77(5):735-745. PubMed ID: 33211137
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of selamectin following intravenous, oral and topical administration in cats and dogs.
Sarasola P; Jernigan AD; Walker DK; Castledine J; Smith DG; Rowan TG
J Vet Pharmacol Ther; 2002 Aug; 25(4):265-72. PubMed ID: 12213114
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic Cefazolin Dosing in Women With Body Mass Index >35 kg·m-2 Undergoing Cesarean Delivery: A Pharmacokinetic Study of Plasma and Interstitial Fluid.
Eley VA; Christensen R; Ryan R; Jackson D; Parker SL; Smith M; van Zundert AA; Wallis SC; Lipman J; Roberts JA
Anesth Analg; 2020 Jul; 131(1):199-207. PubMed ID: 32250982
[TBL] [Abstract][Full Text] [Related]
12. Plasma and urine concentrations of marbofloxacin following single subcutaneous administration to cats.
Kietzmann M; Niedorf F; Kramer S; Hoffmann M; Schneider M; Vallé M; Pankow R
Berl Munch Tierarztl Wochenschr; 2011; 124(1-2):83-8. PubMed ID: 21306059
[TBL] [Abstract][Full Text] [Related]
13. A pilot and feasibility study of the plasma and tissue pharmacokinetics of cefazolin in an immature porcine model of pediatric cardiac surgery.
Kilbaugh TJ; Himebauch AS; Zaoutis T; Jobes D; Greeley WJ; Nicolson SC; Zuppa AF
Paediatr Anaesth; 2015 Nov; 25(11):1111-9. PubMed ID: 26372607
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of cefovecin in cats.
Stegemann MR; Sherington J; Coati N; Brown SA; Blanchflower S
J Vet Pharmacol Ther; 2006 Dec; 29(6):513-24. PubMed ID: 17083455
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of prophylactic cefazolin in parturients undergoing cesarean delivery.
Elkomy MH; Sultan P; Drover DR; Epshtein E; Galinkin JL; Carvalho B
Antimicrob Agents Chemother; 2014 Jun; 58(6):3504-13. PubMed ID: 24733461
[TBL] [Abstract][Full Text] [Related]
16. Intravenous Cefazolin Achieves Sustained High Interstitial Concentrations in Open Lower Extremity Fractures.
Bates TJ; Burgess MB; Garcia GR; Akers KS; Mangum LC; Lynch TB; Wenke JC; Pierrie SN
Clin Orthop Relat Res; 2024 Feb; 482(2):375-383. PubMed ID: 37606954
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and bioavailability of cefazolin in horses.
Sams RA; Ruoff WW
Am J Vet Res; 1985 Feb; 46(2):348-52. PubMed ID: 3994100
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of furosemide after intravenous, oral and transdermal administration to cats.
Sleeper MM; O'Donnell P; Fitzgerald C; Papich MG
J Feline Med Surg; 2019 Oct; 21(10):882-886. PubMed ID: 30339054
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic Study of Cefazolin in Short Daily Hemodialysis.
Palmer K; Walker S; Richardson R; Jassal SV; Battistella M
Ann Pharmacother; 2019 Apr; 53(4):348-356. PubMed ID: 30345801
[TBL] [Abstract][Full Text] [Related]
20. Single-dose pharmacokinetics of cefazolin in bovine synovial fluid after intravenous regional injection.
Gagnon H; Ferguson JG; Papich MG; Bailey JV
J Vet Pharmacol Ther; 1994 Feb; 17(1):31-7. PubMed ID: 8196091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
